genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Eye Disorders

      Prime Editing Reverses Vision Loss in Mice

      3D illustration Rendering of binary code pattern.Futuristic Particles digital Landscape wave Abstract background for business,Science and technology
      Artificial Intelligence

      AI-Proofing Workflows in Drug Development

      Lung Cancer
      Cancer

      New Drug Combo Reduces Lung Tumors in Mice

      Corn crop
      AgBio

      Gene Discovery May Help Effort to Breed Climate Resilient Crops

      RNA strands consisting of nucleotides important for protein bio-synthesis
      Cancer

      Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Abstract Colorful Blue Radial Glitch Chromatic Holographic Background
      Cancer

      Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity

      scientists workin
      Biologics

      Biologics Manufacturing without the Cells

      Bioprocessing

      Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production

      Bioprocessing

      Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Precision Medicine

Precision Medicine

  • 10x Genomics
  • A-Lists
  • AgBio
  • Age-Related Disorders
  • Aging
  • AGTC
  • alcohol
  • Alexandria Real Estate Equities
  • Allergic Diseases
  • Application Notes
  • Artificial Intelligence
  • Autoimmune Disorders
  • Bacterial Diseases
  • Bacteriophage
  • Base Editing
  • Bayer
  • Biodefense/Bioterrorism
  • Bioethics
  • Biomarker Discovery
  • BioNTech
  • BioPerspectives
  • Blockchain
  • Blood Disorders
  • Boehringer Ingelheim
  • Bone disorders
  • Brexit
  • Bristol-Myers Squibb
  • Cardiovascular Disease
  • Careers
  • Celgene
  • Cell Analysis
  • Cell Biology
  • Cell Culture
  • Cell Line Development
  • Cell Signaling
  • Cell Therapy
  • Cellular Analysis
  • China
  • Chromatography
  • Circadian Rhythm
  • Commentary
  • Compound Synthesis
  • Computational Biology
  • Computer Simulation
  • COVID-19 Candidates
  • CRISPR
  • CRISPR/Cas9
  • Danaher
  • Developmental Disorders
  • DNA Repair
  • Drug Resistance
  • Ear Disorders
  • Economic development
  • Education and training
  • Electrophoresis
  • Eli Lilly
  • Employment Trends
  • Endocrine Disorders
  • Evolution
  • Extracellular Matrix
  • Eye Disorders
  • Fill and Finish
  • Financing
  • Flow Cytometry
  • Forensics
  • Fungal Diseases
  • Gastrointestinal Disorders
  • GEN 40
  • GEN Edge
  • Genentech
  • Genetic Disease Testing
  • Genetics
  • Glycan Analysis
  • Glycoproteins
  • GWAS
  • Hematologic Conditions
  • Histology
  • HPLC
  • Hypertension
  • Imaging
  • Immunoassay
  • Immunochemistry
  • Immunology
  • In-vitro Fertilization
  • Industry News
  • Inflammatory Diseases
  • Information Management
  • Insights
  • interleukin
  • Ion Channels
  • Kidney Diseases
  • Kinases
  • Literature Review
  • Liver Diseases
  • Lung Cancer
  • Lung Diseases
  • Magazine
  • Marijuana
    Most popular
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Medicine doctor and stethoscope touching icon heart and diagnostics analysis medical on modern virtual screen interface network connection. Medical technology diagnostics of heart concept
    GENcast

    GENcast: Empowering a Precision Health Movement

    Source: Thermo Fisher Scientific
    Precision Medicine

    New Thermo Fisher Center Offers Access to Precision Medicine Technologies, Expertise

    Variable penetrance has long posed a challenge for predicting the severity of a disease
    Precision Medicine

    Genetic Diseases More Severe with Adverse Coding, Regulatory Variant Combos

    Bayer and The Broad Institute of MIT and Harvard say their newly launched Precision Cardiology Laboratory will use genomic and nongenomic approaches to learn more about heart failure
    Precision Medicine

    Bayer, Broad Institute Launch Precision Cardiology Laboratory

    4i is the first imaging technique which gives a multiplexed tissue-to-organelle view of biological samples and links multiple information in one and the same experiment. [UZH]
    Precision Medicine

    Innovative Immunofluorescence Technique Greatly Refines Cellular Analysis

    Precision Medicine

    Cancer Genetics Reports Record Q3 Revenue

    Precision Medicine

    Diversity of Kids’ Cancer More Epigenetic Than Genetic

    Precision Medicine

    UCB Acquires Element Genomics, with Targeted Therapies in Mind

    N-of-One image
    Precision Medicine

    Precision Medicine: Getting Oncology Drug Development Right

    protein synthesis and ribosome
    Precision Medicine

    Cell Out? Lysate-Based Expression an Option for Personalized Meds

    Precision Medicine

    Creating a Clinical Crystal Ball: SOPHiA Genetics is Democratizing Data-Driven Medicine

    illustration female lab tech looking at brain
    Precision Medicine

    Misfolding Protein May Pave the Road to Personalized Medicine Approach

    Precision Medicine

    Personalized Medicine Study Improves Connection between Genomic and Proteomic Variation

    Precision Medicine

    Konica Minolta to Acquire Ambry Genetics for Up to $1 Billion

    Blood Cells
    Precision Medicine

    Betting on Blood

    123...16Page 1 of 16

    Recently Featured

    Prime Editing Reverses Vision Loss in Mice

    Prime Editing Reverses Vision Loss in Mice

    AI-Proofing Workflows in Drug Development

    AI-Proofing Workflows in Drug Development

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up